Main Session
Sep
29
SS 19 - Palliative Care 1: Palliative Radiotherapy from SABR to EBRT: Improving QOL, Prognostication, and Toxicities
212 - Predictors of Skeletal-Related Events and Quality of Life Dimensions among Patients with High-Risk, Asymptomatic Bone Metastases with or without Early Radiation Therapy: Secondary Analysis of a Multicenter, Randomized Phase II Clinical Trial
Presenter(s)
Kaitlyn Lapen, MD - Memorial Sloan Kettering Cancer Center, New York, NY